It is generally said that neoplastic cells are immunohistochemically negative for glial fibrillary acidic protein (GFAP) in rat spontaneous astrocytomas, and there are no reports describing the existence of GFAP-positive neoplastic astrocytes in rat spontaneous oligodendrogliomas and mixed gliomas which contain neoplastic astrocytes. In the present study, to clarify whether GFAP-positive neoplastic astrocytes exist in rat spontaneous oligodendrogliomas and mixed gliomas or not, immunohistochemical examination was performed on spontaneous oligodendrogliomas (26 cases) and mixed gliomas (5 cases) collected from the carcinogenicity studies and short-term toxicity studies. The neoplastic cells that constitute oligodendrogliomas and mixed gliomas were morphologically classified into five types: round A, round B, round C, spindle, and bizarre. The cells of round A, B, and C types were thought to be neoplastic oligodendrocytes because of their positive immunostainability for Olig2. The origin of bizarre cells was obscure because they were negative for Olig2, GFAP, and nestin. The spindle cells were considered to be neoplastic astrocytes, because some of them were positive for GFAP or nestin, and GFAP-positive spindle cells could be morphologically distinguished from reactive astrocytes. In conclusion, the present study clarified for the first time that GFAP-positive neoplastic astrocytes exist in rat spontaneous gliomas.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0192623312463987 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A novel risk model consisting of nine platelet-related gene signatures for predicting prognosis, immune features and drug sensitivity in glioma.
Hereditas
December 2024
Dalian Medical University, Dalian, Liaoning Province, 116000, China.
Background: Glioma is a malignancy with challenging clinical treatment and poor prognosis. Platelets are closely associated with tumor growth, propagation, invasion, and angiogenesis. However, the role of platelet-related genes in glioma treatment and prognosis remains unclear.
View Article and Find Full Text PDFExploring the Potential of Nasal Drug Delivery for Brain Targeted Therapy: A Detailed Analysis.
Biopharm Drug Dispos
December 2024
Chitkara College of Pharmacy, Chitkara University, Rajpura, India.
Article Synopsis
- The brain is protected by various barriers, including the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB), which regulate what substances can enter, making drug delivery challenging.
- The BBB is a tight junction formed by multiple cell types that prevents solutes from freely diffusing into the brain, while the BCSFB is located at the choroid plexus and is more permeable.
- Nasal drug delivery offers a promising alternative for directly transporting therapies to the brain, and the review discusses its mechanisms, various formulations, clinical trials, and patents, highlighting its potential for targeted drug delivery.
Transcription factors ASCL1 and OLIG2 drive glioblastoma initiation and co-regulate tumor cell types and migration.
Nat Commun
November 2024
Department of Neurosciences, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Glioblastomas (GBMs) are highly aggressive, infiltrative, and heterogeneous brain tumors driven by complex genetic alterations. The basic-helix-loop-helix (bHLH) transcription factors ASCL1 and OLIG2 are dynamically co-expressed in GBMs; however, their combinatorial roles in regulating the plasticity and heterogeneity of GBM cells are unclear. Here, we show that induction of somatic mutations in subventricular zone (SVZ) progenitor cells leads to the dysregulation of ASCL1 and OLIG2, which then function redundantly and are required for brain tumor formation in a mouse model of GBM.
View Article and Find Full Text PDFIntegrated Transcriptome Profiling and Pan-Cancer Analyses Reveal Oncogenic Networks and Tumor-Immune Modulatory Roles for FABP7 in Brain Cancers.
Int J Mol Sci
November 2024
Department of Translational Medicine and Physiology, Elson S. Floyd College of Medicine, Washington State University, Spokane, WA 99202, USA.
Fatty acid binding protein 7 (FABP7) is a multifunctional chaperone involved in lipid metabolism and signaling. It is primarily expressed in astrocytes and neural stem cells (NSCs), as well as their derived malignant glioma cells within the central nervous system. Despite growing evidence for FABP7's tumor-intrinsic onco-metabolic functions, its mechanistic role in regulating the brain tumor immune microenvironment (TIME) and its impact on prognosis at the molecular level remain incompletely understood.
View Article and Find Full Text PDFSingle-cell multi-omics sequencing uncovers region-specific plasticity of glioblastoma for complementary therapeutic targeting.
Sci Adv
November 2024
RNA Institute, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan University, Wuhan 430072, China.
Article Synopsis
- Glioblastoma (GBM) cells exhibit high levels of heterogeneity and invasion, contributing to treatment challenges and recurrences.
- * Researchers collected tumor core and peritumoral brain tissues to analyze the molecular behavior of infiltrating tumor cells, which resemble oligodendrocyte progenitor cells more than astrocytes.
- * The study identifies key transcription factors like AP-1 and BACH1 that influence tumor cell behavior, and suggests that combined targeting of these factors can improve treatment outcomes in GBM mice models.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!